Artiva Biotherapeutics Inc
ARTV
Get informed when a big investor buys or sells
+ FollowMarket Cap$499.66M
Close$
$0.64
93.6% downside
Current Fair Value
93.6% downsideOvervalued by 93.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $499.66 Million |
|---|---|
| Enterprise Value | $208.05 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.43 |
| Beta | 2.2 |
| Outstanding Shares | 39,413,236 |
Return
| Return on Equity | -26.14% |
|---|---|
| Return on Assets | -24.64% |
| Return on Invested Capital | -26.29% |
Valuation & Multiples
| P/E Ratio | -3.09 |
|---|---|
| PEG | -17.5 |
| Price to Sales | - |
| Price to Book Ratio | 1.27 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.23 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
$-0.70
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.54
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 102.47%▲ 34.25% |
|---|---|
| Total Invested | $391.75M▲ 261.32% |
| Investors Holding | 74▲ 34.00% |
ESG Score
No data